Immunotherapy drug Keytruda received FDA approval and showed benefit for treatment of colorectal cancer
Full article:

In June 2020, the FDA approved Keytruda (pembrolizumab) as an initial therapy for advanced colorectal cancer. This approval was based on the results from the KEYNOTE-177 study. In this study, Keytruda was more successful than chemotherapy in delaying progression of certain types of colorectal cancers. (11/25/20)

Questions To Ask Your Health Care Provider

Open Clinical Trials


The following studies are enrolling people with advanced colorectal cancer. 

Several other clinical trials for patients with colorectal cancer can be found here.


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.